Chain Reaction: New Anti-Inflammatory Agents Silence Overactive Immune System

The discovery of a new way to fight inflammation offers a promising new approach to treat inflammatory autoimmune disorders such as lupus and multiple sclerosis, which are marked by an overactive immune response. Read HERE

For those who don't know MS first hand - An Important Excerpt from Wikipedia on MS:

The person with MS can suffer almost any neurological symptom or sign, including changes in sensation (hypoesthesias and paraesthesias), muscle weakness, muscle spasms, or difficulty in moving;^[15] difficulties with coordination and balance (ataxia);^[15] problems in speech (dysarthria) or swallowing (dysphagia),^[16] visual problems (nystagmus, optic neuritis, or diplopia),^[17] fatigue, acute or chronic pain,^[18]^[19] and bladder and bowel difficulties.^[19]^[20] Cognitive impairment of varying degrees and emotional symptoms of depression or unstable mood are also common.^[21]^[22] The main clinical measure of disability progression and symptom severity is the Expanded Disability Status Scale or EDSS.^[23]

Multiple sclerosis relapses are often unpredictable, occurring without warning and without obvious inciting factors. Some attacks, however, are preceded by common triggers. Relapses occur more frequently during spring and summer.^[24] Infections such as the common cold, influenza, or gastroenteritis increase the risk of relapse.^[25]^[26] Stress may also trigger an attack.

Chain Reaction

Monday, August 29, 2011

New Anti-Inflammatory Agents Silence Overactive Immune System

1 comment: